Mobile Apps for the Care Management of Chronic Kidney and End-Stage Renal Diseases: Systematic Search
Mobile Apps for the Care Management of Chronic Kidney and End-Stage Renal Diseases: Systematic Search
复制标题
DOI：
10.2196/12604
复制
发表时间：
2019-09-04
影响因子：
5
通讯作者：
Koizumi, Naoru
中科院分区：
文献类型：
--
作者：
Siddique, Abu Bakkar;Krebs, Mary;Koizumi, Naoru
背景：近年来，许多免费和低成本的用于肾脏疾病护理管理的移动应用程序已经推出。尽管这些工具看起来很有前途，但它们并没有根据标准的移动应用程序指标进行比较评估，因此，关于它们的有效性的证据有限。本研究对慢性肾脏病(CKD)和终末期肾病(ESRD)透析患者用药依从性和营养追踪的手机应用进行了系统的分类和评估。目的：本研究的目的是全面评估慢性肾脏病(CKD)和终末期肾病(ESRD)患者可能使用的用于药物依从性和营养追踪的手机应用。我们使用13个相关搜索词选择应用程序，根据一套纳入和排除标准进行缩小，然后使用移动应用程序评级表(MARS)，这是一种广泛采用的应用程序评估工具来评估应用程序的有效性。结果：MARS总分具有良好的内部一致性(Cronbachα=.90)和中等水平的评定者间信度(双向混合ICC0.65)。总体而言，在接受评估的12款应用程序中，有11款在玛氏评分中达到了3.0的最低可接受分数。综合得分最高的3款应用程序分别是My Kneins、My Health Handbook(MARS=4.68)、My Food Coach(My Food Coach)(MARS=4.48)和马来西亚国家肾脏基金会(MARS=4.20)。这项研究发现了现有应用程序的两个普遍弱点：应用程序缺乏提供激励反馈、促进家庭成员和照顾者参与应用程序使用等高级互动功能。结论：MARS评分系统在应用程序评估中表现良好。排名最靠前的三款应用在玛氏的5个维度上得分都很高。这些应用程序是与声誉良好的组织和领域专家合作开发的，表明了专家指导在开发医疗应用程序中的重要性。
Background: Numerous free and low-cost mobile apps for the care management of kidney disease have become available in recent years. Although these appear to be promising tools, they have not been evaluated comparatively based on standard mobile app metrics, and thus, limited evidence is available regarding their efficacy. This study systematically cataloged and assessed mobile apps designed to assist medication compliance and nutrition tracking that are useful to the chronic kidney disease (CKD) and the end-stage renal disease (ESRD) patients who are on dialysis.Objective: The objective of this study was to comprehensively evaluate mobile apps used for medication compliance and nutrition tracking for possible use by CKD and ESRD patients.Methods: A systematic review framework was applied to the search, screening, and assessment of apps identified and downloaded from the iOS and Android app stores. We selected apps using 13 relevant search terms, narrowed down based on a set of inclusion and exclusion criteria, and then used the Mobile App Rating Scale (MARS), a widely adopted app evaluation tool to assess the effectiveness of apps. The internal consistency and interrater reliability were tested using Cronbach alpha and interclass correlation coefficients (ICCs), respectively.Results: The MARS total score had excellent internal consistency (Cronbach alpha=.90) and a moderate level of interrater reliability (2-way mixed ICC 0.65). Overall, 11 out of the 12 reviewed apps met the minimum acceptable score of 3.0 in MARS rating. The 3 apps with the highest combined scores were My Kidneys, My Health Handbook (MARS=4.68); My Food Coach (MARS=4.48); and National Kidney Foundation Malaysia (MARS=4.20). The study identified 2 general weaknesses in the existing apps: the apps fell short of accommodating advanced interactive features such as providing motivational feedback and promoting family member and caregiver participations in the app utilization.Conclusions: The MARS rating system performed well in the app evaluation. The 3 highest ranked apps scored consistently high across the 5 dimensions specified in MARS. These apps were developed in collaboration with reputable organizations and field experts, demonstrating the importance of expert guidance in developing medical apps.